243 related articles for article (PubMed ID: 23040614)
1. SHIP2 signalling at the plasma membrane, in the nucleus and at focal contacts.
Elong Edimo W; Vanderwinden JM; Erneux C
Adv Biol Regul; 2013 Jan; 53(1):28-37. PubMed ID: 23040614
[TBL] [Abstract][Full Text] [Related]
2. SHIP2 multiple functions: a balance between a negative control of PtdIns(3,4,5)P₃ level, a positive control of PtdIns(3,4)P₂ production, and intrinsic docking properties.
Erneux C; Edimo WE; Deneubourg L; Pirson I
J Cell Biochem; 2011 Sep; 112(9):2203-9. PubMed ID: 21503961
[TBL] [Abstract][Full Text] [Related]
3. Reversible Ser/Thr SHIP phosphorylation: a new paradigm in phosphoinositide signalling?: Targeting of SHIP1/2 phosphatases may be controlled by phosphorylation on Ser and Thr residues.
Edimo WE; Janssens V; Waelkens E; Erneux C
Bioessays; 2012 Aug; 34(8):634-42. PubMed ID: 22641604
[TBL] [Abstract][Full Text] [Related]
4. Evidence of SHIP2 Ser132 phosphorylation, its nuclear localization and stability.
Elong Edimo W; Derua R; Janssens V; Nakamura T; Vanderwinden JM; Waelkens E; Erneux C
Biochem J; 2011 Nov; 439(3):391-401. PubMed ID: 21770892
[TBL] [Abstract][Full Text] [Related]
5. SH2-containing inositol 5-phosphatases 1 and 2 in blood platelets: their interactions and roles in the control of phosphatidylinositol 3,4,5-trisphosphate levels.
Giuriato S; Pesesse X; Bodin S; Sasaki T; Viala C; Marion E; Penninger J; Schurmans S; Erneux C; Payrastre B
Biochem J; 2003 Nov; 376(Pt 1):199-207. PubMed ID: 12885297
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylated SHIP2 on Y1135 localizes at focal adhesions and at the mitotic spindle in cancer cell lines.
Deneubourg L; Elong Edimo W; Moreau C; Vanderwinden JM; Erneux C
Cell Signal; 2014 Jun; 26(6):1193-203. PubMed ID: 24561238
[TBL] [Abstract][Full Text] [Related]
7. Phosphatidylinositol 3,4,5-trisphosphate modulation in SHIP2-deficient mouse embryonic fibroblasts.
Blero D; Zhang J; Pesesse X; Payrastre B; Dumont JE; Schurmans S; Erneux C
FEBS J; 2005 May; 272(10):2512-22. PubMed ID: 15885100
[TBL] [Abstract][Full Text] [Related]
8. SHIP2 controls plasma membrane PI(4,5)P2 thereby participating in the control of cell migration in 1321 N1 glioblastoma cells.
Elong Edimo W; Ghosh S; Derua R; Janssens V; Waelkens E; Vanderwinden JM; Robe P; Erneux C
J Cell Sci; 2016 Mar; 129(6):1101-14. PubMed ID: 26826186
[TBL] [Abstract][Full Text] [Related]
9. Phosphoinositide 5-phosphatases SKIP and SHIP2 in ruffles, the endoplasmic reticulum and the nucleus: An update.
Ramos AR; Ghosh S; Suhel T; Chevalier C; Obeng EO; Fafilek B; Krejci P; Beck B; Erneux C
Adv Biol Regul; 2020 Jan; 75():100660. PubMed ID: 31628071
[TBL] [Abstract][Full Text] [Related]
10. Silencer of death domains (SODD) inhibits skeletal muscle and kidney enriched inositol 5-phosphatase (SKIP) and regulates phosphoinositide 3-kinase (PI3K)/Akt signaling to the actin cytoskeleton.
Rahman P; Huysmans RD; Wiradjaja F; Gurung R; Ooms LM; Sheffield DA; Dyson JM; Layton MJ; Sriratana A; Takada H; Tiganis T; Mitchell CA
J Biol Chem; 2011 Aug; 286(34):29758-70. PubMed ID: 21712384
[TBL] [Abstract][Full Text] [Related]
11. SHIP2 signaling in normal and pathological situations: Its impact on cell proliferation.
Elong Edimo W; Schurmans S; Roger PP; Erneux C
Adv Biol Regul; 2014 Jan; 54():142-51. PubMed ID: 24091101
[TBL] [Abstract][Full Text] [Related]
12. The association between the SH2-containing inositol polyphosphate 5-Phosphatase 2 (SHIP2) and the adaptor protein APS has an impact on biochemical properties of both partners.
Onnockx S; De Schutter J; Blockmans M; Xie J; Jacobs C; Vanderwinden JM; Erneux C; Pirson I
J Cell Physiol; 2008 Jan; 214(1):260-72. PubMed ID: 17620296
[TBL] [Abstract][Full Text] [Related]
13. Regulation of PDGF-stimulated SHIP2 tyrosine phosphorylation and association with Shc in 3T3-L1 preadipocytes.
Artemenko Y; Gagnon A; Ibrahim S; Sorisky A
J Cell Physiol; 2007 Jun; 211(3):598-607. PubMed ID: 17219406
[TBL] [Abstract][Full Text] [Related]
14. Regulation of endogenous SH2 domain-containing inositol 5-phosphatase (SHIP2) in 3T3-L1 and human preadipocytes.
Gagnon A; Artemenko Y; Crapper T; Sorisky A
J Cell Physiol; 2003 Nov; 197(2):243-50. PubMed ID: 14502564
[TBL] [Abstract][Full Text] [Related]
15. How does SHIP1/2 balance PtdIns(3,4)P2 and does it signal independently of its phosphatase activity?
Xie J; Erneux C; Pirson I
Bioessays; 2013 Aug; 35(8):733-43. PubMed ID: 23650141
[TBL] [Abstract][Full Text] [Related]
16. Phosphoinositide 5-phosphatase activities control cell motility in glioblastoma: Two phosphoinositides PI(4,5)P2 and PI(3,4)P2 are involved.
Ramos AR; Elong Edimo W; Erneux C
Adv Biol Regul; 2018 Jan; 67():40-48. PubMed ID: 28916189
[TBL] [Abstract][Full Text] [Related]
17. The role of the inositol polyphosphate 5-phosphatases in cellular function and human disease.
Ooms LM; Horan KA; Rahman P; Seaton G; Gurung R; Kethesparan DS; Mitchell CA
Biochem J; 2009 Apr; 419(1):29-49. PubMed ID: 19272022
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of SH2-containing inositol phosphatase 2 results in negative regulation of insulin-induced metabolic actions in 3T3-L1 adipocytes via its 5'-phosphatase catalytic activity.
Wada T; Sasaoka T; Funaki M; Hori H; Murakami S; Ishiki M; Haruta T; Asano T; Ogawa W; Ishihara H; Kobayashi M
Mol Cell Biol; 2001 Mar; 21(5):1633-46. PubMed ID: 11238900
[TBL] [Abstract][Full Text] [Related]
19. The SH2 domain containing inositol polyphosphate 5-phosphatase-2: SHIP2.
Dyson JM; Kong AM; Wiradjaja F; Astle MV; Gurung R; Mitchell CA
Int J Biochem Cell Biol; 2005 Nov; 37(11):2260-5. PubMed ID: 15964236
[TBL] [Abstract][Full Text] [Related]
20. Serum withdrawal-induced accumulation of phosphoinositide 3-kinase lipids in differentiating 3T3-L6 myoblasts: distinct roles for Ship2 and PTEN.
Mandl A; Sarkes D; Carricaburu V; Jung V; Rameh L
Mol Cell Biol; 2007 Dec; 27(23):8098-112. PubMed ID: 17893321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
